Evidence map›Paper›PMID 21988913›Full record

ArticleNature communications2011

A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death.

Jeffrey Atkinson, Alexandr A Kapralov, Naveena Yanamala, Yulia Y Tyurina, Andrew A Amoscato, Linda Pearce, Jim Peterson, Zhentai Huang, Jianfei Jiang, Alejandro K Samhan-Arias and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Cardiolipin Membranes Promote CytochromeMolecules (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Redox Pioneer: Professor Valerian Kagan.Antioxidants & redox signaling · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Targeting Lipid Peroxidation for Cancer Treatment.Molecules (Basel, Switzerland) · 2020
    Review
  15. Targets for protection and mitigation of radiation injury.Cellular and molecular life sciences : CMLS · 2020
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 1 institution in 3 countries.

Jeffrey AtkinsonCenter for Free Radical and Antioxidant Health and Center for Medical Countermeasures against Radiation, University of Pittsburgh, Bridgeside Point, Pennsylvania 15219, USA.
Alexandr A Kapralov
Naveena Yanamala
Yulia Y Tyurina
Andrew A Amoscato
Linda Pearce
Jim Peterson
Zhentai Huang
Jianfei Jiang
Alejandro K Samhan-Arias
Akihiro Maeda
Weihong Feng
Karla Wasserloos
Natalia A Belikova
Vladimir A Tyurin
Hong Wang
Jackie Fletcher
Yongsheng Wang
Irina I Vlasova
Judith Klein-Seetharaman
Detcho A Stoyanovsky
Hülya Bayîr
Bruce R Pitt
Michael W Epperly
Joel S Greenberger
Valerian E Kagan
University of Pittsburgh · US

Funding

Training and EducationU19AI068021 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GREENBERGER, JOEL S · 2005 to 2019
$44.4M
Pulmonary Phosphatidylserine Oxidation in ApoptosisR01HL070755 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2002 to 2011
$3.0M
Lung Oxidative Stress/Inflammation By Carbon NanotubesR01OH008282 · OH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2005 to 2014
$2.8M
Mechanism of Irradiation Pulmonary FibrosisR01CA119927 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GREENBERGER, JOEL S · 2008 to 2012
$1.4M
Irradiation Damage and Protection of Pulmonary Endothelium Oxidative LipidomicsR01HL094488 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2009 to 2010
$758k
Cytochrome c mechanism of ROS signaling in apoptosisR03TW007320 · FIC · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2007 to 2009
$116k
FIC NIH HHS R03 TW007320NCI NIH HHS R01 CA119927NHLBI NIH HHS R01 HL070755NHLBI NIH HHS R01 HL094488NIAID NIH HHS U19 AI068021NIOSH CDC HHS R01 OH008282
6 · The paper itself

Abstract

The risk of radionuclide release in terrorist acts or exposure of healthy tissue during radiotherapy demand potent radioprotectants/radiomitigators. Ionizing radiation induces cell death by initiating the selective peroxidation of cardiolipin in mitochondria by the peroxidase activity of its complex with cytochrome c leading to release of haemoprotein into the cytosol and commitment to the apoptotic program. Here we design and synthesize mitochondria-targeted triphenylphosphonium-conjugated imidazole-substituted oleic and stearic acids that blocked peroxidase activity of cytochrome c/cardiolipin complex by specifically binding to its haem-iron. We show that both compounds inhibit pro-apoptotic oxidative events, suppress cyt c release, prevent cell death, and protect mice against lethal doses of irradiation. Significant radioprotective/radiomitigative effects of imidazole-substituted oleic acid are observed after pretreatment of mice from 1 h before through 24 h after the irradiation.

Indexed as

AnimalsCell DeathCytochrome-c PeroxidaseElectron Spin Resonance SpectroscopyEnzyme InhibitorsFemaleMiceMice, Inbred C57BLMitochondriaModels, MolecularMolecular Dynamics SimulationRadiation-Protective AgentsCytochrome-c PeroxidaseEnzyme InhibitorsRadiation-Protective Agents

Identifiers

PMID21988913
PMCPMC3557495
OpenAlexW2004706975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.